What are the treatment options for epistaxis (nosebleed)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Epistaxis (Nosebleeds)

For most cases of nosebleeds, first-line treatment should involve firm sustained compression to the lower third of the nose for at least 5 minutes, and if bleeding continues, compression should be maintained for a full 15 minutes. 1

Initial Management

  • Distinguish patients requiring prompt management from those who don't - assess for airway compromise, hemodynamic instability, or severe blood loss that would require emergency department evaluation 1
  • Position the patient sitting with head slightly forward to prevent blood from draining into the throat 2
  • Apply firm sustained compression to the soft part (lower third) of the nose for 5-15 minutes continuously 1, 2
  • Clear any blood clots before attempting to identify the bleeding site 1
  • Perform anterior rhinoscopy to identify the source of bleeding after clot removal 1

First-Line Interventions

  • For active bleeding that persists after compression, use topical vasoconstrictors such as oxymetazoline or phenylephrine nasal spray, which can stop 65-75% of nosebleeds 1, 3
    • Apply by first clearing clots, then spraying twice in the bleeding nostril and continuing compression for 5 minutes 2
  • For identified bleeding sites, treatment options include:
    • Topical vasoconstrictors (as above) 1
    • Nasal cautery (chemical or electrical) after proper anesthesia of the site 1
    • Moisturizing or lubricating agents to prevent recurrence 1

Advanced Interventions

  • For persistent bleeding, nasal packing should be used 1
    • Options include non-absorbable materials (petroleum jelly, BIPP gauze, PVA nasal tampons) or absorbable materials (Nasopore) 3
    • For patients on anticoagulants or with bleeding disorders, use resorbable packing 1
    • Educate patients about the type of packing placed, removal timing (if non-resorbable), and post-procedure care 1
  • For difficult cases requiring specialized management:
    • Nasal endoscopy should be performed to identify bleeding sites when anterior rhinoscopy is insufficient 1
    • For recurrent bleeding despite prior treatment with packing or cautery, referral for endoscopic evaluation is recommended 1

Management for Refractory Cases

  • Evaluate candidacy for surgical arterial ligation or endovascular embolization for patients with persistent or recurrent bleeding not controlled by packing or cauterization 1
  • In the absence of life-threatening bleeding, initiate first-line treatments before considering transfusion, reversal of anticoagulation, or withdrawal of anticoagulant/antiplatelet medications 1

Prevention of Recurrence

  • Educate patients about preventive measures 1:
    • Avoid digital trauma (nose picking) and vigorous nose blowing 1
    • Use nasal saline and moisturizing gels to lubricate the nasal mucosa 1, 4
    • Consider using a humidifier, especially during dry seasons or in dry environments 4
  • After cauterization, instruct patients to avoid nose blowing, strenuous activity, and heavy lifting for at least a week 1, 4

Special Considerations

  • For children, digital trauma (nose picking) is the most common cause of nosebleeds 4
  • For patients with recurrent bilateral nosebleeds or family history of recurrent nosebleeds, assess for nasal and oral mucosal telangiectasias (potential hereditary hemorrhagic telangiectasia) 1
  • Document outcomes within 30 days for patients treated with non-resorbable packing, surgery, or arterial ligation/embolization 1

When to Seek Additional Medical Care

  • Bleeding that doesn't stop after 15 minutes of proper compression 2
  • Signs of significant blood loss (dizziness, weakness, tachycardia) 2
  • Recurrent nosebleeds despite preventative measures 4
  • Nosebleeds associated with trauma, foreign bodies, or suspected underlying medical conditions 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Epistaxis in Patients on Ozempic (Semaglutide)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Guideline

Management of Epistaxis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.